InvestorsHub Logo
Sticky
West2

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
misterfishman Free
10:09 AM
Post #153,806
profile icon
Box Money Free
10:07 AM
Post #153,805
profile icon
Post #153,803
profile icon
chris6789 Free
10/01/23 10:59 AM
Post #153,802
Bullish
Bullish
profile icon
fink PremiumMember
10/01/23 9:18 AM
Post #153,801
profile icon
misterfishman Free
10/01/23 8:02 AM
Post #153,800
profile icon
fink PremiumMember
09/30/23 8:14 PM
Post #153,799
profile icon
Timing101 Free
09/30/23 12:39 PM
Post #153,798
profile icon
misterfishman Free
09/30/23 12:26 PM
Post #153,797
profile icon
BDEZ PremiumMember
09/29/23 10:42 PM
Post #153,796
profile icon
misterfishman Free
09/29/23 7:46 PM
Post #153,795
profile icon
misterfishman Free
09/29/23 7:40 PM
Post #153,794
profile icon
Livi1 Free
09/29/23 7:17 PM
Post #153,793
profile icon
Livi1 Free
09/29/23 6:54 PM
Post #153,792
profile icon
TerraRyzing Free
09/29/23 5:35 PM
Post #153,791
profile icon
West2 Free
09/29/23 4:56 PM
Post #153,790
profile icon
West2 Free
09/29/23 4:52 PM
Post #153,789
profile icon
PennyMillions852 Free
09/29/23 4:22 PM
Post #153,787
profile icon
Sputnik PremiumMember
09/29/23 4:20 PM
Post #153,786
profile icon
PennyMillions852 Free
09/29/23 3:55 PM
Post #153,784
profile icon
J2003 PremiumMember
09/29/23 3:39 PM
Post #153,783
profile icon
J2003 PremiumMember
09/29/23 3:39 PM
Post #153,782
profile icon
misterfishman Free
09/29/23 3:36 PM
Post #153,781
profile icon
Timing101 Free
09/29/23 3:29 PM
Post #153,780
profile icon
MattyTrader PremiumMember
09/29/23 3:07 PM
Post #153,779
profile icon
misterfishman Free
09/29/23 2:29 PM
Post #153,778
profile icon
misterfishman Free
09/29/23 2:15 PM
Post #153,777
profile icon
PennyMillions852 Free
09/29/23 2:11 PM
Post #153,776
profile icon
fink PremiumMember
09/29/23 2:09 PM
Post #153,775
profile icon
misterfishman Free
09/29/23 1:03 PM
Post #153,774
profile icon
misterfishman Free
09/29/23 1:01 PM
Post #153,773
profile icon
misterfishman Free
09/29/23 12:55 PM
Post #153,772
profile icon
PennyMillions852 Free
09/29/23 12:49 PM
Post #153,771
profile icon
misterfishman Free
09/29/23 12:46 PM
Post #153,770
profile icon
PennyMillions852 Free
09/29/23 11:46 AM
Post #153,769
profile icon
misterfishman Free
09/29/23 11:31 AM
Post #153,768
profile icon
J2003 PremiumMember
09/29/23 11:27 AM
Post #153,767
profile icon
misterfishman Free
09/29/23 11:11 AM
Post #153,766
profile icon
PennyMillions852 Free
09/29/23 11:01 AM
Post #153,765
profile icon
chris6789 Free
09/29/23 10:59 AM
Post #153,764
Bullish
Bullish
profile icon
misterfishman Free
09/29/23 10:48 AM
Post #153,763
profile icon
MattyTrader PremiumMember
09/29/23 10:45 AM
Post #153,762
profile icon
PennyMillions852 Free
09/29/23 10:30 AM
Post #153,761
profile icon
PennyMillions852 Free
09/29/23 10:25 AM
Post #153,760
profile icon
misterfishman Free
09/29/23 10:22 AM
Post #153,759
profile icon
misterfishman Free
09/29/23 10:21 AM
Post #153,758
profile icon
fink PremiumMember
09/29/23 10:07 AM
Post #153,757

Strategic Asset Leasing Inc (LEAS)

Followers
938
Posters
Posts (Today)
4
Posts (Total)
153806
Created
10/19/07
Type
Free
Moderators i_like_bb_stock Zardiw DTGoody BDEZ West2 trader59

ANew Medical Inc.

Symbol: LEAS



$LEAS Summary DD (True Value .057/Share):

$LEAS is merging with $RWOD (Nasdaq, $10/share).

$LEAS has approved (Europe) drugs for anti-aging, etc ... Website: https://www.anewmeds.com/
Now they want to get FDA approval for the US.

$LEAS Shares will be converted to $RWOD Shares.

175 $LEAS Shares will become 1 $RWOD Share.

175 x .057 = $10.

So the True Value is .057/share.

All this info came from the 8K that $RWOD filed: https://www.sec.gov/ix?doc=/Archives/edgar/data/1907223/000121390023045945/ea179544-8k_redwoods.htm

Here is the Calculation using the info from the 8K:

"be converted into the right to receive a number of shares of Redwoods Common Stock equal to the Merger Consideration."

“Merger Consideration” means with respect to each outstanding share of Company Common Stock a number of shares of Redwoods Common Stock equal to the Exchange Ratio (and with an aggregate value equal to the Closing Equity Value), allocated to the Company Stockholders as set forth on the Allocation Schedule.

“Exchange Ratio” means (a) the Closing Equity Value Per Share, divided by (b) the Redwoods Share Value.

== .057 / 10 == .0057

“Closing Equity Value Per Share” means (a) the Closing Equity Value, divided by (b) the Fully Diluted Company Capitalization.

== $60M / 1045M = .057

“Closing Equity Value” means $60,000,000.

“Fully Diluted Company Capitalization” means, without duplication, the sum of the aggregate number of shares of Company Common Stock outstanding as of immediately prior to the Effective Time, determined on an as-converted basis (including, for the avoidance of doubt, the number of shares of Company Common Stock issuable upon conversion of any outstanding convertible securities of the Company).

== Outstanding = 1045M

“Redwoods Share Value” means $10.00.

Exchange Ratio for 1 Share:

1 Share of RWOD / .0057 = 175. SO 175 LEAS shares will convert to 1 share of RWOD.

175 Shares currently is worth 175 x .0022 = .385. So .385 current value converts to $10. == 26 Bagger.

$10 / 175 = .057/Share == TRUE Value of $LEAS Shares.


Here are the values at different price points:

.0022 = 26 Bagger
.0050 = 11 Bagger
.01 = 6 Bagger
.02 = 3 Bagger

And investors that hold shares through the Merger will realize .057/Share conversion value

....................Currently working on this...................................
ANEW MEDICAL, INC. has acquired pharmaceutical and biotechnology assets in the medical oncology, biologics, and gene therapy sectors of the pharmaceutical and biotechnology industry. The company is considering several financing vehicles.

Medical product development and commercialization. The Company recently acquired five generic oncology drugs approved and manufactured in Germany and they plan to gain approval for these drugs in the US in 2023. The Company is preparing for a pivotal Phase 3 study of an anti-cancer antibody product that is highly similar to Genentech/Roche's brand name Avastin (bevacizumab), the Company has licensed a needle-free jet injector for drug delivery, and the Company is in the pre-clinical stages of development of a gene therapy product candidate based on the delivery of a human alpha-Klotho gene and protein to prevent and/or treat neurodegenerative diseases such as Alzheimer's